Terumo Pharmaceutical Solutions wins Asia-Pacific Industry Award

Tokyo-based Terumo Corporation (TSE: 4543) has today announced  that Terumo Pharmaceutical Solutions  has been awarded the Asia-Pacific Bioprocessing Excellence Award 2020 on July 7th at the Asia- Pacific Bio processing Excellence awards 2020.

It was the third year in a row for Terumo Pharmaceutical Solutions to win the award. The event for the year was held virtually owing to COVID-19.

Terumo Pharmaceutical Solutions was nominated in the category, 'Best Bioprocessing Supplier Award: "Prefillable Syringes" and competed with several other established companies in the industry.

Ashit Sikka, Business Director, Terumo Pharmaceutical Solutions, India accepted this award on behalf of Terumo.

 "We are very excited about the interest our PLAJEX™ platform continues to receive on the market and look forward to supporting our customer's future requirements", commented Marco Chiadò Piat, President, Terumo Pharmaceutical Solutions.

The Asia-Pacific Bioprocessing Excellence Award organized by IMAPAC, seeks to give recognition to exceptional biopr ocessing experts, organizations and technologies that facilitate biomanufacturing excellence at enhanced speed, r educed cost and superior quality. Featuring top bioprocessing and biomanufacturing leaders in the industry, along with the latest advances in technologies and best practices in manufacturing, the Asia-Pacific Bioprocessing Excellence Awards applaud extraordinary leaders & trend-setters of today, and inspire innovators of tomorrow.

An esteemed panel of expert judges and the Biologics Manufacturing Asia committee shortlisted the nominees that have proven to be outstanding in their respective categories. They include key opinion leaders with more than 20 years of experience, Process Development Vice Presidents and Directors, Heads of Manufacturing and bioprocessing from all the key players in both Asia and on a global level.